Nosocomial Bacterial Pneumonia in HIV-Infected Patients: Risk Factors for Adverse Outcome and Implications for Rational Empiric Antibiotic Therapy

被引：0
|
作者：
F. Franzetti
A. Grassini
M. Piazza
M. Degl’Innocenti
A. Bandera
L. Gazzola
G. Marchetti
A. Gori
机构：
[1] University of Milano,Institute of Infectious and Tropical Diseases
[2] Clinica delle Malattie Infettive—Ospedale “L. Sacco”,undefined
来源：
Infection | 2006年 / 34卷
关键词：
Staphylococcus; Pseudomonas Aeruginosa; Streptococcus Pneumoniae; Methicillin; Bacterial Pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 16
页数：7
相关论文
共 50 条
  • [21] Pneumonia in HIV-infected patients: a case-control survey of factors involved in risk and prevention
    Guerrero, M
    Kruger, S
    Saitoh, A
    Sorvillo, F
    Cheng, KJ
    French, C
    Beall, G
    AIDS, 1999, 13 (14) : 1971 - 1975
  • [22] Prevalence of cardiovascular risk factors in HIV-infected patients
    Jerico, C.
    Knobel, H.
    Sorli, M. L.
    Montero, M.
    Guelar, A.
    Pedro-Botet, J.
    REVISTA CLINICA ESPANOLA, 2006, 206 (11): : 556 - 559
  • [23] Risk factors for cryptococcal meningitis in HIV-infected patients
    Oursler, KAK
    Moore, RD
    Chaisson, RE
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (07) : 625 - 631
  • [24] BACTERIAL PNEUMONIA IN HIV-INFECTED PATIENTS - A PROSPECTIVE-STUDY OF 68 EPISODES
    FALCO, V
    DESEVILLA, TF
    ALEGRE, J
    BARBE, J
    FERRER, A
    OCANA, I
    RIBERA, E
    MARTINEZVAZQUEZ, JM
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (02) : 235 - 239
  • [25] Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients
    José Antonio Mata-Marín
    Gloria Huerta-García
    Juan Carlos Domínguez-Hermosillo
    Marcelino Chavez-García
    Marco Isaac Banda-Lara
    Nohemí Nuñez-Rodríguez
    Javier Enrique Cruz-Herrera
    Jorge Luis Sandoval-Ramírez
    Ivan Martínez-Abarca
    Alfredo Francisco Villagómez-Ruíz
    Bulmaro Manjarrez-Tellez
    Jesús Gaytán-Martínez
    AIDS Research and Therapy, 12
  • [26] Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients
    Antonio Mata-Marin, Jose
    Weiser Smeke, Ariane Estrella
    Rotzinger Rodriguez, Mariana
    Chavez-Garcia, Marcelino
    Isaac Banda-Lara, Marco
    Perez Rios, Alma Minerva
    Nunez-Rodriguez, Nohemi
    Carlos Dominguez-Hermosillo, Juan
    Chaparro Sanchez, Alberto
    Juarez-Kasusky, Irene
    Cruz Herrera, Javier Enrique
    Sandoval Ramirez, Jorge Luis
    Gaytan-Martinez, Jesus
    DRUGS IN R&D, 2017, 17 (01) : 225 - 231
  • [27] Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients
    Antonio Mata-Marin, Jose
    Huerta-Garcia, Gloria
    Carlos Dominguez-Hermosillo, Juan
    Chavez-Garcia, Marcelino
    Isaac Banda-Lara, Marco
    Nunez-Rodriguez, Nohemi
    Enrique Cruz-Herrera, Javier
    Luis Sandoval-Ramirez, Jorge
    Martinez-Abarca, Ivan
    Francisco Villagomez-Ruiz, Alfredo
    Manjarrez-Tellez, Bulmaro
    Gaytan-Martinez, Jesus
    AIDS RESEARCH AND THERAPY, 2015, 12
  • [28] Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients
    José Antonio Mata-Marín
    Ariane Estrella Weiser Smeke
    Mariana Rotzinger Rodriguez
    Marcelino Chávez-García
    Marco Isaac Banda-Lara
    Alma Minerva Pérez Rios
    Nohemí Nuñez-Rodríguez
    Juan Carlos Domínguez-Hermosillo
    Alberto Chaparro Sánchez
    Irene Juarez-Kasusky
    Javier Enrique Cruz Herrera
    Jorge Luis Sandoval Ramírez
    Jesús Gaytán-Martínez
    Drugs in R&D, 2017, 17 : 225 - 231
  • [29] Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects
    Donati, KD
    Bertagnolio, S
    Tumbarello, M
    Tacconelli, E
    Cataldo, M
    Longo, B
    Cauda, R
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (03) : 357 - 360
  • [30] MICROBIOLOGY OF COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA IN PERSONS WITH AND AT RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - IMPLICATIONS FOR RATIONAL EMPIRIC ANTIBIOTIC-THERAPY
    BURACK, JH
    HAHN, JA
    SAINTMAURICE, D
    JACOBSON, MA
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (22) : 2589 - 2596
12345